Lusaris Therapeutics Inc
  • Home
  • Our Approach
  • About Us
  • Pipeline
  • News
  • Careers
Select Page

In the News

Lusaris: Treating Depression with a New Version of an Old Psychotropic

Nov 8, 2022 | BioCentury

RA Capital Backs Another Startup Hunting for a Better Antidepressant

Nov 2, 2022 | BioPharma Dive 

Lusaris Launches with $60M to Advance Psychedelic-Based Depression Therapeutic

Nov. 2, 2022 | BioSpace

Lusaris Therapeutics, Inc.
630 Davis Drive, Suite 220
Morrisville, NC 27560
919.294.6409

Media inquiries: media@lusaristx.com
General inquiries: info@lusaristx.com

  • Home
  • Our Approach
  • About Us

Privacy Policy

  • Pipeline
  • News
  • Careers
  • Follow
  • Follow

Lusaris Therapeutics, Inc.
Media inquiries: media@lusaristx.com
General inquiries: info@lusaristx.com

630 Davis Drive, Suite 220
Morrisville, NC 27560
919.294.6409

  • Home
  • Our Approach
  • About Us
  • Pipeline
  • News
  • Careers

Privacy Policy

  • Follow
  • Follow